Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

by Lindsay, C. R., Le Moulec, S., Billiot, F., Loriot, Y., Ngo-Camus, M., Vielh, P., Fizazi, K., Massard, C., Farace, F.
Published in BMC Cancer (2016)

P13.14 Use of Foundation one CDx for molecular screening in patients with primary brain tumors: Gustave Roussy Experience

by Baldini, C, Boulfoul, W, Lacroix, L, Rouleau, E, Scoazec, J, Varga, A, Hollebecque, A, Ribrag, V, Soria, J, Massard, C
Published in Neuro Oncol (2019)

A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

by Boven, E, Massard, C, Armand, J P, Tillier, C, Hartog, V, Brega, N M, Countouriotis, A M, Ruiz-Garcia, A, Soria, J C
Published 2010

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

by Massard, C, Voigt, J-J, Laplanche, A, Culine, S, Lortholary, A, Bugat, R, Theodore, C, Priou, F, Kaminsky, M-C, Lesimple, T, Pivot, X, Coudert, B, Douillard, J-Y, Merrouche, Y, Fizazi, K
Published 2007

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

by Massard, C, Voigt, J-J, Laplanche, A, Culine, S, Lortholary, A, Bugat, R, Theodore, C, Priou, F, Kaminsky, M-C, Lesimple, T, Pivot, X, Coudert, B, Douillard, J-Y, Merrouche, Y, Fizazi, K
Published 2008

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

by Farace, F, Massard, C, Vimond, N, Drusch, F, Jacques, N, Billiot, F, Laplanche, A, Chauchereau, A, Lacroix, L, Planchard, D, Le Moulec, S, André, F, Fizazi, K, Soria, J C, Vielh, P
Published 2011

Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone

by Massard, C., Mateo, J., Loriot, Y., Pezaro, C., Albiges, L., Mehra, N., Varga, A., Bianchini, D., Ryan, C. J., Petrylak, D. P., Attard, G., Shen, L., Fizazi, K., de Bono, J.
Published in Ann Oncol (2017)

OS4.3 Feasibility and benefit of Molecular Profiling to Guide Enrollment of Patients with Recurrent Gliomas in Early Phase Trials

by Baldini, C, Younan, N, Castanon Alvarez, E, Bahleda, R, Hollebecque, A, Dhermain, F, Ammari, S, Alentorn, A, Dumont, S, Frenel, J, Di Stefano, A, Bielle, F, Hoang-Xuan, K, Delattre, J, Soria, J, Sanson, M, Idbaih, A, Massard, C, Touat, M
Published in Neuro Oncol (2019)